期刊文献+

转基因与移植耐受研究进展

下载PDF
导出
摘要 近年来 ,通过诱导免疫耐受延长移植物存活的研究 ,已取得了可喜的进步。特别是分子生物学、分子免疫学和基因转移技术的不断进步 ,对移植耐受的诱导也产生了重要的影响。
出处 《国外医学(泌尿系统分册)》 2005年第1期68-72,共5页 Foreign Medical Sciences(Urology and Nephrology Foreign Medical Sciences)
  • 相关文献

参考文献20

  • 1Chao DT,Korsmeger SJ.Bcl-2 family:regulatorof cell death.Ann Rev Immunol,1998,16:395-419. 被引量:1
  • 2Tanaka M,Suda T,Haze K,et al.Fas ligand in human serum.Nature Med,1996,2:317-322. 被引量:1
  • 3White WL,Zhang YL,Shelby J,et al.Myocardial apoptosis in a heterotopic murine heart transplantation model of chronic rejection and graft vasculopathy.J Heart Lung Transplant,1997,16(2):250-255. 被引量:1
  • 4Strehlau J,Pavlakis M,Lipman M,et al.Quantitative detection of immune activation transcripts as a diagnostictool in kidney transplantation.Pro Natl Acad Sci USA,1997,94(2):695-700. 被引量:1
  • 5Baker MB,Riley RL,Podack ER,et al.Graft-versus-host-disease-associated lymphoid hypoplasia and B cell dysfunction is dependent upon donor T cell-mediated Fas-ligand function ,but not perforin function.Pro Natl Acad Sci USA,1997,94(4):1366-1371. 被引量:1
  • 6Griffith TS,Brunner T,Fletcher SM,et al.Fas ligand induced apoptosis as a mechanism of immune privilege.Science,1995,270:1189-1192. 被引量:1
  • 7Kang SM,Schneider DB,Lin Z,et al.Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction.Nature Med,1997,3:738-743. 被引量:1
  • 8Muruve DA,Nicolson AC,Manfro RC,et al.Adenovirus-mediated expression of Fas Ligand induces hepatic apoptosis after systemic administration and apoptosis Of ex vivo-infected pancreatic islet allografts and isografts,Hum GeneTher,1997,8:955-963. 被引量:1
  • 9Li XK,Okuyama T,Tamura A,et al.Prolonged survival Of rat liver allografts transfected with Fas Ligand-expressing plasmid.Transplantation,1998,66(11):1416-1423. 被引量:1
  • 10Najafian N,Sayegh MH.CTLA4-Ig:a novel immunosuppressive agent.Expert Opin Investing Drugs,2000,9:2147-2157. 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部